ARCHIVES

Avastin doubles progression-free survival in metastatic disease.

This article is from The Cancer Letter archive.

Vol. 31 No. 21 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

NCI RFA Available: Minority-Based CCOPS

August 15, 1997

NCI Must Build a Research Community In Pancreatic Cancer, Review Groups Says.

March 9, 2001

Longer List of DCPC Spending Plans $40 Mll Increase

December 10, 1993

DCPC Board Approves Concept for New Nutrition Grants

February 10, 1989

NCCN’s First Physician CEO: Robert Carlson Pledges Broader Research and Policy Agenda

October 5, 2012

Panel Objects To Act Change Requiring NCI Carcinogen Report

May 12, 1978